Inventor · disambiguated record
George N. Pavlakis
Also filed as: PAVLAKIS GEORGE · PAVLAKIS GEORGE N
40 granted patents·14 pending applications·1,608 citations·filing 1992–2024
98Inventor score
Files withUS HEALTH24NOVARTIS AG4PAVLAKIS GEORGE N4FELBER BARBARA K3THE US SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES3
Top patents by PatentIndex Score
54 records- 0199US6414132B1Method of eliminating inhibitory/instability regions of mRNAUS HEALTH·Filed 2000·Granted Jul 2, 2002·155 cites·27 claims
- 0298US6794498B2Method of eliminating inhibitory/instability regions of mRNAUS HEALTH·Filed 2001·Granted Sep 21, 2004·160 cites·4 claims
- 0398US5965726AMethod of eliminating inhibitory/ instability regions of mRNAUS HEALTH·Filed 1997·Granted Oct 12, 1999·290 cites·36 claims
- 0497US6291664B1Method of eliminating inhibitory/instability regions of mRNAUS HEALTH·Filed 1999·Granted Sep 18, 2001·185 cites·48 claims
- 0597US6174666B1Method of eliminating inhibitory/instability regions from mRNAUS HEALTH·Filed 1992·Granted Jan 16, 2001·214 cites·11 claims
- 0696US5972596ANucleic acid constructs containing HIV genes with mutated inhibitory/instability regions and methods of using sameUS HEALTH·Filed 1994·Granted Oct 26, 1999·133 cites·22 claims
- 0795US9725492B2Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cellsTHE US SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES·Filed 2015·Granted Aug 8, 2017·13 cites·21 claims
- 0894US6770291B2Liposome complexes for increased systemic deliveryUS HEALTH·Filed 2001·Granted Aug 3, 2004·95 cites·7 claims
- 0994US6265548B1Mutant Aequorea victoria fluorescent proteins having increased cellular fluorescenceUS HEALTH·Filed 2000·Granted Jul 24, 2001·52 cites·9 claims
- 1093US9931377B2Cell expressing complexes of IL-15 and IL-15RalphaPAVLAKIS GEORGE N·Filed 2008·Granted Apr 3, 2018·23 cites·23 claims
- 1193US9790261B2Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cellsTHE US SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES·Filed 2015·Granted Oct 17, 2017·10 cites·26 claims
- 1293US8871191B2Use of IL-15 preparations to treat lymphopeniaPAVLAKIS GEORGE N·Filed 2010·Granted Oct 28, 2014·18 cites·15 claims
- 1392US9975937B2Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopeniaTHE US SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES·Filed 2014·Granted May 22, 2018·8 cites·4 claims
- 1492US9303080B2Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cellsFELBER BARBARA K·Filed 2007·Granted Apr 5, 2016·14 cites·7 claims
- 1590US10428133B2Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cellsUS HEALTH·Filed 2017·Granted Oct 1, 2019·3 cites·27 claims
- 1690US10093710B2Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopeniaTHE US SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES·Filed 2017·Granted Oct 9, 2018·3 cites·17 claims
- 1789US8715964B2Expression of IL-12 family heterodimersFELBER BARBARA K·Filed 2009·Granted May 6, 2014·10 cites·9 claims
- 1889US7833754B2IL-12 for expression in mammalian cellUS HEALTH·Filed 2007·Granted Nov 16, 2010·21 cites·18 claims
- 1989US6027881AMutant Aequorea victoria fluorescent proteins having increased cellular fluorescenceUS HEALTH·Filed 1996·Granted Feb 22, 2000·77 cites·21 claims
- 2088US10894816B2Use of IL-15 to increase thymic output and to treat lymphopeniaUS GOV HEALTH & HUMAN SERVICES·Filed 2018·Granted Jan 19, 2021·2 cites·11 claims
- 2187US8586055B2DNA immunization protocolsFELBER BARBARA·Filed 2008·Granted Nov 19, 2013·7 cites·6 claims
- 2287US6656706B2Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genesUS HEALTH·Filed 2001·Granted Dec 2, 2003·15 cites·22 claims
- 2385US7288266B2Liposome complexes for increased systemic deliveryUS HEALTH·Filed 2006·Granted Oct 30, 2007·5 cites·3 claims
- 2485US7001614B2Liposome complexes for increased systemic deliveryUS HEALTH·Filed 2004·Granted Feb 21, 2006·23 cites·2 claims
- 2584US9546202B2Expression of IL-12 family heterodimersUS HEALTH·Filed 2014·Granted Jan 17, 2017·3 cites·16 claims
- 2684US7094408B2Immunogenicity using a combination of DNA and vaccinia virus vector vaccinesUS HEALTH·Filed 2001·Granted Aug 22, 2006·12 cites·14 claims
- 2783US10335460B2IL-15 and IL-15Rα heterodimer dose escalation regimens for treating conditionsNOVARTIS AG·Filed 2015·Granted Jul 2, 2019·4 cites·19 claims
- 2883US10265382B2Complexes of IL-15 and IL-15Ralpha and uses thereofNOVARTIS AG·Filed 2017·Granted Apr 23, 2019·4 cites·12 claims
- 2983US9415099B2Method of altering the immundominance hierarchy of HIV gag by DNA vaccine expressing conserved regionsTHE US SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES·Filed 2013·Granted Aug 16, 2016·3 cites·19 claims
- 3083US7771729B2Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant administration of DNA and ALVAC expression vectorsUS HEALTH·Filed 2006·Granted Aug 10, 2010·2 cites·14 claims
- 3182US11110150B2Complexes of IL-15 and IL-15Ralpha and uses thereofNOVARTIS AG·Filed 2019·Granted Sep 7, 2021·1 cites·4 claims
- 3277US11041008B2Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopeniaUS GOV HEALTH & HUMAN SERVICES·Filed 2018·Granted Jun 22, 2021·1 cites·12 claims
- 3377US2025108092A1Il-15r alpha forms, cells expressing il-15r alpha forms, and therapeutic uses of il-15r alpha and il-15/il-15r alpha complexesNOVARTIS AG·Filed 2024·Application pending·0 cites
- 3475US11167025B2Altering the immundominance hierarchy using a DNA vaccine expressing conserved regionsUS HEALTH·Filed 2019·Granted Nov 9, 2021·0 cites·19 claims
- 3573US10426830B2Altering the immundominance hierarchy using a DNA vaccine expressing conserved regionsTHE US SECRETARY OF THE DEPARTMENT OF HEALTH·Filed 2016·Granted Oct 1, 2019·1 cites·18 claims
- 3673US7608422B2Simian immunodeficiency virus (SIV) molecular clone encoding mutant gag gene lacking inhibitory/instability regionsUS HEALTH·Filed 2003·Granted Oct 27, 2009·4 cites·8 claims
- 3770US11339198B2Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cellsUS HEALTH·Filed 2019·Granted May 24, 2022·0 cites·25 claims
- 3870US2023340029A1Methods and compositions for inducing an immune response using conserved element constructsTHE US SECRETARY DEPARTMENT OF·Filed 2023·Application pending·0 cites
- 3970US2025360199A1Immunogens and methods for inducing an immune responseUS HEALTH·Filed 2023·Application pending·0 cites
- 4069US8076100B2Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genesPAVLAKIS GEORGE N·Filed 2002·Granted Dec 13, 2011·3 cites·12 claims
- 4167US6413544B1Liposome complexes for increased systemic deliveryUS HEALTH·Filed 1997·Granted Jul 2, 2002·32 cites·3 claims
- 4261US2009227664A1Expression Vectors Able to Elicit Improved Immune Response and Methods of Using SameUS HEALTH·Filed 2009·Application pending·0 cites
- 4358US2019209653A1Il-15r alpha forms, cells expressing il-15r alpha forms, and therapeutic uses of il-15r alpha and il-15/il-15r alpha complexesUS GOV HEALTH & HUMAN SERV·Filed 2018·Application pending·0 cites
- 4457US2015359853A1Il-15r alpha forms, cells expressing il-15r alpha forms, and therapeutic uses of il-15r alpha and il-15/il-15r alpha complexesADMUNE THERAPEUTICS LLC·Filed 2013·Application pending·0 cites
- 4556US2012027792A1Expression vectors able to elicit improved immune response and methods of using samePAVLAKIS GEORGE N·Filed 2011·Application pending·0 cites
- 4654US8163542B2Potent combinations of mRNA transport elementsFELBER BARBARA·Filed 2004·Granted Apr 24, 2012·0 cites·29 claims
- 4753US2004241140A1Expression vectors able to elicit improved immune response and methods of using sameFiled 2001·Application pending·0 cites
- 4852US2018346520A1Methods and compositions for inducing an immune response using conserved element constructsTHE US SECRETARY OF THE DEPARTMENT OF HEALTH AND·Filed 2016·Application pending·0 cites
- 4948US2006188872A1Novel post-transcriptional regulatory elements and uses thereofGOV OF THE USA AS REPRESENTED·Filed 2005·Application pending·0 cites
- 5047US2010291037A1Immunogenicity using a combination of dna and vaccinia virus vector vaccinesUS OF AMERICA AS REPRESENTED B·Filed 2010·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when George N. Pavlakis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →